Dean Falb

Dean Falb

Company: LogicBio

Job title: Chief Scientific Officer

Seminars:

A Stable & Durable Treatment for Pediatric Patients with Hemophilia 10:00 am

Canonical gene therapy cannot be used to treat pediatric patients due to episomal DNA dilution and lack of therapeutic durability GeneRide provides a safe and durable platform for treating pediatric hemophilia patients through insertion of therapeutic transgenes into the chromosome Preclinical data in Hemophilia B mouse models demonstrates the safety and efficacy of this therapeutic…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.